EUVIMEDEUVIMED entdecken
CrossrefInfokarte

ANALYSIS OF THE DIAGNOSTIC ALGORITHM FOR PREDICTING MALIGNANCY IN THYROID NODULES

Tayyaba Ayaz, Qaviullah Mian, Muhammad Naeem, Mushtaq Ahmad

NORTHWEST JOURNAL OF MEDICAL SCIENCES · 2022

DOI: 10.69723/njms.01.02.0250 ↗
AbstractBibliografische Angaben

Abstract

INTRODUCTION: In the past 20 years thyroid nodules have become increasingly common, occurring in almost 50-60 % of the world population. Rapid advances in ultrasound have helped in detecting smaller nodules, which are yet impalpable, contributing to the rise in frequency. Thyroid nodules generally tend to be benign, but about 15% retain malignant potential. The diagnostic algorithm for predicting malignancy in thyroid nodules is a complex algorithm which relies on patient history, presence of known risk factors, ultrasound evaluation and FNA biopsy to assess thyroid disease. OBJECTIVE: The objective of this study was to assess the sequential contribution of each diagnostic technique in the algorithm for predicting malignancy in thyroid nodules. SUBJECT AND METHODS: This retrospective study was done on 137 patients who had dominant nodules and underwent excision. Clinical factors were used to formulate a baseline regression model to predict malignancy. In a periodic fashion, the 2015 ATA ultrasound risk stratification and Bethesda classification were added to the model. The likelihood ratio test was used to assess the significance of each step. RESULTS: The addition of American Thyroid Association risk stratification and Bethesda classification to preceding models were statistically significant (P < .001). The areas under the curve of the baseline model and models sequentially including American Thyroid Association stratification and cytopathology were 0.76, 0.85 and 0.91 respectively CONCLUSION: Clinical factors, sonographic characteristics, and cytopathology are sufficiently accurate in predicting malignancy risk of most thyroid nodules. Key words: Thyroid nodules, thyroid algorithm, Bethesda Classification, malignancy.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →